Kathryn Ball

Kathryn Ball is the Director of Clinical Pharmacology and Pharmacometrics at AstraZeneca, where they focus on developing new immuno-oncology therapies and antibody drug conjugates. Prior to this role, Kathryn served as an Associate Director and Senior Clinical Pharmacologist at AstraZeneca, contributing expertise in pharmacokinetics and regulatory strategy. They held various positions at Servier from 2014 to 2018, specializing in PBPK and PK/PD modeling across multiple therapeutic areas. Kathryn earned a Ph.D. in PBPK modeling from Université Paris Descartes, where they graduated with the highest distinction.